Breaking News Instant updates and real-time market news.

AGN

Allergan

$198.41

-7.11 (-3.46%)

05:06
10/17/17
10/17
05:06
10/17/17
05:06

Allergan price target lowered to $251 from $262 at Deutsche Bank

Deutsche Bank analyst Gregg Gilbert lowered his price target for Allergan shares to $251 saying yesterday's adverse federal court ruling opens the door to potential generic Restasis launches. Even though Allergan plans to appeal the ruling, the analyst lowered his estimates to reflect generic competition materializing in 2019 versus a prior assumption of 2024. Gilbert keeps a Buy rating on Allergan. He believes a "significant hit" to Restasis is now largely factored in at current share levels.

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

AGN Allergan
$198.41

-7.11 (-3.46%)

10/16/17
JPMS
10/16/17
NO CHANGE
JPMS
Overweight
JPMorgan says generic Restasis risk already 'well reflected' in Allergan shares
After a judge ruled Allergan's Restasis patents are invalid, JPMorgan analyst Chris Schott said the news "clearly represents a setback" but he also believes the financial risk of generic Restasis competition is already "well reflected" in the stock. Given that, the news could represent a "clearing event," added Schott, who keeps an Overweight rating on Allergan.
10/16/17
WELS
10/16/17
NO CHANGE
WELS
Outperform
Court ruling looks 'clearly negative' for Allergan, says Wells Fargo
Wells Fargo analyst David Maris says a federal judge ruling today that Allergan's (AGN) Restasis patents are invalid "appears clearly negative" for the company. Due to the magnitude of the potential damages involved, however, an at-risk generic launch is unlikely, Maris tells investors in an intraday research note. As such, the analyst continues to believe the earliest that a generic version of Restasis may enter the market is sometime in 2019. Maris keeps an Outperform rating on Allergan. He adds that today's court ruling is incrementally positive for generic Restasis filers, if approved, including Teva (TEVA), Mylan ( MYL) and Akorn (AKRN).
10/16/17
COWN
10/16/17
NO CHANGE
COWN
Outperform
Cowen says Allergan investors may now 'move past' Restasis patent loss
After an adverse ruling from a federal court on Allergan's patents for Restasis, Cowen analyst Ken Cacciatore believes that it is fair to assume generics beginning in early 2019. While this had long been feared, it also had long been modeled by many, including Cacciatore, who called the news a "clearing event" that investors will now likely "finally be able to move past." The analyst, who said Allergan's growth beyond an assumed 2019 Restasis generic "looks as solid as any in the biopharmaceutical industry," keeps an Outperform rating on the stock.
10/13/17
WELS
10/13/17
NO CHANGE
Target $276
WELS
Outperform
Allergan settlement leaves three Restasis challengers, say Wells Fargo
Wells Fargo analyst David Maris says three Restasis generic challengers remain after Allergan (AGN) reached a settlement with InnoPharma. The settlement, which allows InnoPharma to launch a generic Restasis in the U.S. beginning February 24, 2024, or six months before the expiration of Allergan's patents, points to the complexity of Restasis and the difficulty of getting a generic version approved, Maris tells investors in a research note. InnoPharma was one of four included in a consolidated lawsuit against Allergan, with Teva (TEVA), Mylan (MYL) and Akorn (AKRX) remaining, Maris points out. He's encouraged that the settlement date reached with InnoPharma is close to the expiration date of the patents. The analyst keeps an Outperform rating on Allergan with a $276 price target.

TODAY'S FREE FLY STORIES

AVA

Avista

$51.64

-0.19 (-0.37%)

16:14
11/21/17
11/21
16:14
11/21/17
16:14
Hot Stocks
Avista shareholders approve acquisition by Hydro One at $53 per share »

Avista Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

AXTA

Axalta Coating

$33.85

0.31 (0.92%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

16:14
11/21/17
11/21
16:14
11/21/17
16:14
Periodicals
Axalta Coating, AkzoNobel abandon merger talks, WSJ says »

Axalta Coating (AXTA) and…

AXTA

Axalta Coating

$33.85

0.31 (0.92%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.48

1.11 (1.03%)

16:12
11/21/17
11/21
16:12
11/21/17
16:12
Hot Stocks
Salesforce CEO: 'We're on a path to exceed $20 billion' »

"Salesforce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

CRM

Salesforce

$108.58

1.21 (1.13%)

16:11
11/21/17
11/21
16:11
11/21/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Salesforce »

Salesforce reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

HPQ

HP Inc.

$22.45

0.33 (1.49%)

16:10
11/21/17
11/21
16:10
11/21/17
16:10
Hot Stocks
HP Inc. drops 6% in afterhours trading after earnings, guidance »

HP Inc. shares are down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.55

1.18 (1.10%)

16:10
11/21/17
11/21
16:10
11/21/17
16:10
Hot Stocks
Salesforce reports deferred revenue $4.39B, up 26% y/y »

Up 24% in constant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

HPE

HP Enterprise

$14.15

0.055 (0.39%)

16:09
11/21/17
11/21
16:09
11/21/17
16:09
Earnings
Breaking Earnings news story on HP Enterprise »

HP Enterprise backs FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 11

    Dec

GME

GameStop

$16.64

0.2 (1.22%)

16:09
11/21/17
11/21
16:09
11/21/17
16:09
Earnings
GameStop sees FY17 EPS $3.10-$3.40, consensus $3.31 »

Sees FY17 comparable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.45

1.0775 (1.00%)

16:09
11/21/17
11/21
16:09
11/21/17
16:09
Earnings
Salesforce sees FY19 revenue $12.45B-$12.5B »

An increase of 19%-20%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

QADB

QAD Inc

$31.74

1.74 (5.80%)

16:08
11/21/17
11/21
16:08
11/21/17
16:08
Earnings
QAD sees FY18 revenue $300M-$302M, consensus $294.59M »

FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.335 (1.51%)

16:08
11/21/17
11/21
16:08
11/21/17
16:08
Hot Stocks
HP Inc. says results demonstrate HP 'strong and getting stronger' »

"Our results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.60

1.24 (1.16%)

16:08
11/21/17
11/21
16:08
11/21/17
16:08
Earnings
Salesforce raises FY18 adjusted EPS view to $1.32-$1.33 from $1.29-$1.31 »

FY18 consensus $1.32.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

HPE

HP Enterprise

$14.16

0.065 (0.46%)

16:08
11/21/17
11/21
16:08
11/21/17
16:08
Hot Stocks
HP Enterprise announces Antonio Neri to replace Meg Whitman as CEO »

Hewlett Packard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 11

    Dec

QADB

QAD Inc

$31.74

1.74 (5.80%)

16:07
11/21/17
11/21
16:07
11/21/17
16:07
Earnings
QAD reports Q3 GAAP EPS (1c), consensus 7c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.45

0.33 (1.49%)

16:07
11/21/17
11/21
16:07
11/21/17
16:07
Earnings
HP Inc. raises FY18 EPS view to $1.75-$1.85, consensus $1.79 »

For FY18, HP raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

HPE

HP Enterprise

$14.16

0.065 (0.46%)

16:06
11/21/17
11/21
16:06
11/21/17
16:06
Earnings
Breaking Earnings news story on HP Enterprise »

HP Enterprise sees Q1 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 11

    Dec

GME

GameStop

$16.52

0.075 (0.46%)

16:06
11/21/17
11/21
16:06
11/21/17
16:06
Earnings
GameStop reports Q3 EPS 54c, consensus 43c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.69

1.315 (1.22%)

16:06
11/21/17
11/21
16:06
11/21/17
16:06
Earnings
Salesforce sees Q4 adjusted EPS 32c-33c, consensus 34c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

HPQ

HP Inc.

$22.45

0.33 (1.49%)

16:06
11/21/17
11/21
16:06
11/21/17
16:06
Earnings
Breaking Earnings news story on HP Inc. »

HP Inc. sees Q1 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ILMN

Illumina

$212.05

1.38 (0.66%)

16:06
11/21/17
11/21
16:06
11/21/17
16:06
Hot Stocks
Illumina wins infringement suit against Premaith Health, Ariosa Diagnostics »

Illumina announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

HPE

HP Enterprise

$14.16

0.065 (0.46%)

16:06
11/21/17
11/21
16:06
11/21/17
16:06
Earnings
HP Enterprise reports Q4 EPS 31c, consensus 28c »

Reports Q4 revenue $7.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

  • 11

    Dec

HPQ

HP Inc.

$22.46

0.335 (1.51%)

16:05
11/21/17
11/21
16:05
11/21/17
16:05
Earnings
HP Inc. reports Q4 EPS 44c, consensus 44c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$108.76

1.39 (1.29%)

16:05
11/21/17
11/21
16:05
11/21/17
16:05
Earnings
Salesforce reports Q3 adjusted EPS 39c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

HIFS

Hingham Institution

$201.40

3.33 (1.68%)

16:04
11/21/17
11/21
16:04
11/21/17
16:04
Hot Stocks
Hingham Institution declares special dividend of 34c per share »

Hingham Institution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$92.98

-0.41 (-0.44%)

16:03
11/21/17
11/21
16:03
11/21/17
16:03
Hot Stocks
Galapagos NV initiates phase 1 CF study of GLPG3221 »

Galapagos NV announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.